LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "cabergoline" as a keyword



Anti‐Inflammatory Effect of Dopamine D2 Receptor Agonist Cabergoline Against L‐Arginine‐Induced Acute Pancreatitis in Rats

Sign Up to like & get
recommendations! Published in 2025 at "Journal of Biochemical and Molecular Toxicology"

DOI: 10.1002/jbt.70370

Abstract: Severe acute pancreatitis (SAP) is an inflammatory disorder of the pancreas that may extend to other organs resulting in systemic injury. Unfortunately, there is no specific treatment beyond supportive management. Therefore, the current study explores… read more here.

Keywords: cabergoline; arginine; cab; sap ... See more keywords

Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model

Sign Up to like & get
recommendations! Published in 2020 at "Archives of Gynecology and Obstetrics"

DOI: 10.1007/s00404-020-05855-1

Abstract: Purpose Ovarian hyperstimulation syndrome (OHSS) is a life-threatening complication of ovarian stimulation in reproductive medicine. Here, we aimed to investigate the role of oxytocin (OT) and cabergoline in the prevention and alleviation of the OHSS… read more here.

Keywords: ovarian hyperstimulation; group; oxytocin cabergoline; cabergoline ... See more keywords

Dopamine agonist withdrawal in hyperprolactinemia: when and how

Sign Up to like & get
recommendations! Published in 2017 at "Endocrine"

DOI: 10.1007/s12020-017-1469-0

Abstract: Dopaminergic agents (DA) have been commonly used to treat hyperprolactinemia since the late 1970’s. Since the mid 1990’s, after a seminal study that showed it to be more effective and better tolerated than bromocriptine [1],… read more here.

Keywords: hyperprolactinemia; patients treated; paper; cabergoline ... See more keywords

Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study

Sign Up to like & get
recommendations! Published in 2025 at "Endocrine"

DOI: 10.1007/s12020-025-04215-w

Abstract: Due to the low incidence of male microprolactinoma, there is a paucity of data in the literature regarding its management. Our aim was to investigate the long-term outcomes of cabergoline treatment in men with microprolactinoma.… read more here.

Keywords: cabergoline; cabergoline treatment; cohort; treatment ... See more keywords

Maladie de cushing récidivante traitée par cabergoline : à propos d’un cas

Sign Up to like & get
recommendations! Published in 2018 at "Annales d'Endocrinologie"

DOI: 10.1016/j.ando.2018.06.471

Abstract: Introduction La cabergoline est un agoniste dopaminergique qui a montre son efficacite dans le traitement des prolactinomes. Certains ont opte pour ce traitement dans la MC recidivante non controlee par les traitements habituels. Nous decrivons… read more here.

Keywords: cushing cidivante; par; maladie cushing; cabergoline ... See more keywords

Efficacité de la cabergoline sur les prolactinomes géants, à propos d’un cas

Sign Up to like & get
recommendations! Published in 2018 at "Annales d'Endocrinologie"

DOI: 10.1016/j.ando.2018.06.484

Abstract: Introduction Les adenomes geants representent entre 0,4 et 4 % des adenomes hypophysaires. Les prolactinomes font exception dans la prise en charge de ces adenomes geants puisqu’ils peuvent beneficier le plus souvent d’un traitement medical en… read more here.

Keywords: prolactine; efficacit cabergoline; traitement; cabergoline ... See more keywords

The Role of Dopamine Agonists in Pituitary Adenomas.

Sign Up to like & get
recommendations! Published in 2020 at "Endocrinology and metabolism clinics of North America"

DOI: 10.1016/j.ecl.2020.05.006

Abstract: Dopamine agonist therapy is the primary therapy for prolactin-secreting adenomas and usually results in normoprolactinemia, eugonadism, and tumor reduction. Cabergoline is superior to bromocriptine with regard to efficacy and tolerance. Withdrawal of cabergoline can be… read more here.

Keywords: dopamine agonists; agonists pituitary; pituitary adenomas; cabergoline ... See more keywords

Seasonal Assessment of Duration of Prolactin Suppression Following Cabergoline Treatment in Mares: Unstimulated Versus Sulpiride and Thyrotropin‐Releasing Hormone‐Stimulated Responses

Sign Up to like & get
recommendations! Published in 2017 at "Journal of Equine Veterinary Science"

DOI: 10.1016/j.jevs.2017.08.004

Abstract: Abstract Experiments 1 through 4 were performed to test the hypothesis that season affects the duration of prolactin suppression by a single injection of the dopaminergic agonist, cabergoline. In each, six mares received cabergoline intramuscularly… read more here.

Keywords: prolactin suppression; prolactin; treatment; cabergoline ... See more keywords

Comparison of cabergoline versus calcium infusion in ovarian hyperstimulation syndrome prevention: A randomized clinical trial

Sign Up to like & get
recommendations! Published in 2018 at "Middle East Fertility Society Journal"

DOI: 10.1016/j.mefs.2018.05.001

Abstract: Abstract Aim To compare effectiveness of calcium infusion (CI) versus oral cabergoline (OC) in lowering the incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high risk women undergoing in vitro-fertilization (IVF)/intracytoplasmic sperm injection (ICSI)… read more here.

Keywords: incidence; trial; cabergoline; calcium ... See more keywords

Early onset of cabergoline therapy for prophylaxis from ovarian hyperstimulation syndrome (OHSS): A potentially safer and more effective protocol.

Sign Up to like & get
recommendations! Published in 2019 at "Reproductive biology"

DOI: 10.1016/j.repbio.2019.03.005

Abstract: Vascular endothelial growth factor (VEGF) is the most important angiogenic mediator in ovarian hyperstimulation syndrome OHSS. Studies proved that cabergoline administration blocks the increase in vascular permeability via dephosphorylation of VEGF receptors and hence can… read more here.

Keywords: ohss; ovarian hyperstimulation; high risk; cabergoline ... See more keywords

Endonasal Chiasmapexy Using Autologous Cartilage/Bone for Empty Sella Syndrome After Cabergoline Therapy for Prolactinoma.

Sign Up to like & get
recommendations! Published in 2019 at "World neurosurgery"

DOI: 10.1016/j.wneu.2018.10.012

Abstract: BACKGROUND Visual field deterioration caused by secondary empty sella after cabergoline therapy for prolactinoma is a rare event. Chiasmapexy is performed to treat empty sella syndrome. Although various materials have been used for the elevation… read more here.

Keywords: sella; chiasmapexy; cabergoline; bone ... See more keywords